WILLIAM ROBERT STEVENS, M.D.

Plain English
This study examined how well the BD MAX MDR-TB test can identify tuberculosis (TB) and measure drug resistance using sputum and tongue swabs from patients in South Africa. It found that the test accurately detected TB in sputum samples 88.7% of the time and correctly identified drug resistance in most cases. Using tongue swabs also showed promise, especially when treated with a specific buffer, though more extensive studies are needed to confirm these findings. This is important because quicker and more accurate TB testing can lead to faster treatment, reducing the spread of the disease. Who this helps: Patients being tested for tuberculosis and healthcare providers.

Plain English
Researchers studied a method to detect muscle problems in patients with systemic sclerosis (SSc). They found that 9.9% of patients screened showed muscle involvement, and using the new screening approach increased the detection of inflammatory myopathy (IM) by about 4.5 times compared to usual care. This is important because early identification and treatment of muscle issues can significantly improve patient outcomes. Who this helps: This benefits patients with systemic sclerosis who are at risk for muscle involvement.

Plain English
This study looked at digestive problems in patients with systemic sclerosis (SSc) to understand the different symptoms they experience. Researchers analyzed data from 773 patients and found four main types of gastrointestinal symptoms: problems in the upper digestive tract, bloating, diarrhea and incontinence, and constipation. They also identified two groups of patients based on how severe their symptoms were and how long they had the disease, noting that those with more severe issues often had certain antibodies and lung problems. Understanding these different symptom groups can lead to better treatments that improve daily life for patients. Who this helps: This benefits patients with systemic sclerosis and their doctors by providing insights for more targeted care.

Plain English
This study looked at two different squatting techniques in young people with a hip condition called femoroacetabular impingement syndrome (FAIS). It found that participants squatted deeper and with better joint flexibility during a regular squat compared to a squat where they paused for three seconds at the bottom; specifically, they squatted down 42.6% compared to 36.0% in the pause squat. Understanding these differences is important because it can help guide rehabilitation and exercise programs for people with FAIS to improve their outcomes. Who this helps: Patients with femoroacetabular impingement syndrome.

Plain English
This study examined how often patients with systemic sclerosis (SSc) experience gastrointestinal issues linked to the gut-brain connection. Among 101 patients surveyed, 21 had functional dyspepsia (FD) and 18 had irritable bowel syndrome (IBS), which were associated with more severe gastrointestinal problems and lower quality of life. Understanding these connections is important because it highlights that addressing gut-brain disorders could improve the health and well-being of SSc patients. Who this helps: This helps patients with systemic sclerosis and their doctors.

Plain English
This study looked at the risk of sudden cardiac death (SCD) in people with systemic sclerosis, a rare autoimmune disease. Among 1,708 patients studied, 32 experienced SCD, which is about 1.9% or an incidence rate of 300 deaths per 100,000 person-years—3 to 9 times higher than typical rates in the general population. Key risk factors for SCD included older age, a history of coronary artery disease, reduced heart function, and smoking history, showing that addressing these factors could help manage risk in patients with this condition. Who this helps: This information benefits patients with systemic sclerosis and their doctors.

Plain English
Researchers developed a set of criteria for identifying heart problems related to systemic sclerosis, a serious autoimmune disease that can be life-threatening. They tested these criteria on 168 patients and found that a score of 11 or higher could accurately identify heart involvement with 78% sensitivity and 96% specificity, meaning it was very good at correctly distinguishing between patients with these issues and those who did not have them. This is important because it allows for a more standardized way to diagnose heart involvement in systemic sclerosis, helping improve research and treatment. Who this helps: This helps patients with systemic sclerosis and their doctors by providing clearer guidelines for diagnosis and treatment.

Plain English
This study examined three different ways doctors assess patients with systemic sclerosis, a serious autoimmune disease. Researchers looked at data from nearly 2,000 patients and found that the assessments were closely related at individual visits, but the changes in assessment scores matched only half the time. This matters because it indicates that different assessment tools measure different aspects of the disease, highlighting the need for a standardized approach to improve patient evaluations and outcomes. Who this helps: Patients with systemic sclerosis and their healthcare providers.

Plain English
This study looked at how the weather, specifically the season, temperature, and humidity, affects the symptoms of Raynaud phenomenon (RP) in people with systemic sclerosis. Among nearly 2,000 patients, 26.7% reported worsened RP in the month before their check-ups. The research found that lower temperatures and higher humidity levels increased the severity of RP, significantly impacting patients' quality of life. Who this helps: This helps patients with systemic sclerosis and their doctors in managing RP symptoms.

Plain English
This study looked at the long-term effects of empagliflozin, a medication for patients with chronic kidney disease, after clinical testing ended. It found that patients who took empagliflozin experienced better outcomes: 26.2% of those in the empagliflozin group experienced kidney issues or cardiovascular death, compared to 30.3% in the placebo group. This is important because it shows that empagliflozin not only helps during treatment but may also continue to provide benefits in the months after stopping the medication. Who this helps: Patients with chronic kidney disease.

Plain English
This study examined how immunosuppressive drugs (ISs) affect organ damage in patients with early systemic sclerosis (SSc), a disease that can harm various body organs. Researchers found that among patients with limited cutaneous SSc (lcSSc), those who had taken ISs had lower damage scores, with 34% of the 210 patients using these drugs. However, for those with diffuse cutaneous SSc (dcSSc), where 76% of the 192 patients used ISs, the drugs did not impact damage scores. Who this helps: This research benefits patients with limited cutaneous SSc by highlighting the potential advantages of taking immunosuppressive drugs early in their treatment.

Plain English
This study looked at how frailty affects patients with systemic sclerosis (SSc), a chronic illness, by analyzing the health of over 1,700 patients. Researchers found that 14% of patients were frail and 53% were pre-frail, with 33% showing no signs of frailty. Importantly, 40% of those who were initially frail either stayed frail or improved, highlighting that frailty can change over time and influences health outcomes such as survival. Who this helps: This information benefits patients with systemic sclerosis and their healthcare providers by improving understanding of frailty management.

Plain English
This study looked at how effective self-collected tongue swabs can be for detecting tuberculosis in people in South Africa. Researchers found that these tongue swabs were 78.1% effective at confirming TB presence (meaning they missed about 22% of infections), but they were 100% accurate in identifying people who didn't have the disease. This matters because easier testing options can help more people access TB diagnostics, especially those who might have trouble visiting clinics. Who this helps: This helps patients, especially those who are busy or fear stigma related to TB testing.

Plain English
This study looked at whether aspirin and omega-3 fatty acids can help prevent age-related macular degeneration (AMD) in adults with diabetes. Over 7.4 years, they found that 1.6% of participants taking aspirin developed AMD, compared to 1.8% taking a placebo, while 1.7% of those taking omega-3s developed AMD, just like those on placebo. Ultimately, neither treatment showed a meaningful benefit for preventing AMD, which is important for understanding possible treatments for this eye disease. Who this helps: This helps patients with diabetes who are concerned about eye health.

Plain English
This study compared different immunosuppressive treatments for patients with diffuse cutaneous systemic sclerosis (dcSSc). The researchers found that patients receiving mycophenolate mofetil (MMF) had a significant improvement in skin symptoms, with a reduction of 10.8 points on a skin score scale compared to just 4.8 points for those not on immunosuppressive therapy. Additionally, lung function remained stable in patients on MMF, while it declined by about 160 mL in those not receiving treatment. This research emphasizes the importance of using MMF, especially for patients in the early stages of the disease and those with specific antibodies that indicate a higher risk for lung problems. Who this helps: Patients with diffuse cutaneous systemic sclerosis, particularly those in the early stages of the disease.

Plain English
This study looked at how long it takes to diagnose lymphoma in people with HIV who undergo a specific type of testing called fine needle aspiration. Out of 146 participants, 21 were diagnosed with lymphoma, and nearly half of these patients (10) died either before starting treatment or before they could be officially diagnosed, emphasizing the urgent need for quicker diagnoses. The average time from when patients first saw a doctor to when they received their diagnosis was 85 days, and improving this process could save lives. Who this helps: Patients with HIV at risk for lymphoma.

Plain English
This research looked at how effectively a single test can detect both tuberculosis (TB) and COVID-19 from sputum samples in South Africa. Out of over a thousand participants, the test found COVID-19 in 18% and TB in 3%, with about 1% co-infected with both illnesses. This is significant because it highlights that using a combined testing approach can uncover additional cases of TB, including drug-resistant strains that might otherwise go unnoticed. Who this helps: This benefits patients at risk for both TB and COVID-19, healthcare providers, and public health officials.

Plain English
This study looked at how to measure important changes in health for patients with scleroderma using a specific tool called the Scleroderma Clinical Trials Consortium Damage Index. Researchers examined data from 1,672 patients and found that a change of about 1 unit in this index is what patients recognize as a significant change in their health over a year. This finding is important because it helps doctors and researchers understand how to better assess patient progress and make treatment decisions. Who this helps: This helps patients with scleroderma and their healthcare providers.

Plain English
This study looked at how having multiple health issues (called multimorbidity) affects people with systemic sclerosis (SSc), a type of autoimmune disease. Out of 2,000 participants, 20% had multimorbidity, which included conditions like high blood pressure (81%) and heart disease (40%). Those with multimorbidity had a 57% higher risk of dying than those without, and it also reduced their physical function significantly, suggesting that treating other health problems could lead to better outcomes for SSc patients. Who this helps: This information is valuable for doctors and patients managing systemic sclerosis and its related health issues.

Plain English
This study looked at the causes of organ damage and early death in patients with systemic sclerosis (SSc) by comparing the autopsy results of 59 SSc patients to 59 matched individuals who died in motor vehicle accidents. It found that patients with SSc had significantly higher rates of heart and lung damage, including 11 times more cases of heart muscle scarring and up to 100 times more lung damage due to inflammation and other issues. Understanding these differences helps clarify why patients with SSc face a higher risk of sudden cardiac death and organ failure. Who this helps: This research benefits patients with systemic sclerosis and their doctors by providing insights into their health risks.

Plain English
This study focused on how to better detect specific DNA sequences related to lymphoma in patients using techniques that analyze their blood plasma. The researchers found that using a method called paramagnetic bead-based isolation of cfDNA led to a higher recovery rate of this tumor-related DNA compared to another method, and they also discovered that improved library preparation methods helped in accurately sequencing important genetic markers. Optimizing these techniques could lead to more reliable diagnosis and monitoring of lymphoma. Who this helps: This helps lymphoma patients and their doctors by providing better tools for monitoring the disease.

Plain English
This study looked at how often people with systemic sclerosis (a type of autoimmune disease) in Australia are given immunosuppressant medications and what factors influence this. It found that 60% of the 2,019 participants used immunosuppressants, with 81% of those having the more severe form of the disease (diffuse systemic sclerosis) receiving them. Over the years, the use of disease-modifying anti-rheumatic drugs increased from 35% to 56%, while the use of prednisolone decreased from 24% to 17%, indicating a shift towards earlier and different treatments. Who this helps: This benefits patients with systemic sclerosis and their doctors by highlighting effective treatment options.

Plain English
This study looked at how effective pegcetacoplan, a treatment for geographic atrophy (GA) related to age-related macular degeneration (AMD), is on improving eyesight and quality of life for patients over two years. The results showed that patients with GA lesions farther (≥ 250 µm) from the center of the eye had a slight improvement in vision (+5.6 points) and quality of life (+4.0 points), while those with lesions closer (<250 µm) did not show significant changes. This matters because it indicates that pegcetacoplan could help slow the decline in vision and life quality for some patients affected by GA. Who this helps: This helps patients with geographic atrophy from age-related macular degeneration.

Plain English
This study looked at how lung function declines in patients with interstitial lung disease related to systemic sclerosis, which is a serious condition that affects the lungs. Researchers tracked 444 patients and found four different patterns of lung function decline: one group had a rapid decline of -2.18% per year, and this group was nearly three times more likely to die than those with slower declines. Understanding these patterns is important because it helps identify patients at higher risk for worse health outcomes early on. Who this helps: This helps patients and doctors by providing insight into who may need more aggressive monitoring and treatment for lung disease.

Plain English
This study looked at how fenofibrate, a medication, compares to standard care in slowing down diabetic retinopathy, a complication of diabetes that affects the eyes. It found that patients taking fenofibrate had a 4.4% reduction in the progression of their eye disease within two years and lower overall healthcare costs, saving about £254 over the same period. This treatment is important because it not only helps maintain eye health but is also cost-effective, making it a viable option for the healthcare system. Who this helps: This helps patients with early diabetic eye disease and their doctors.

Plain English
This study looked at how physical function changes over time in people with systemic sclerosis (SSc), a condition that can limit daily activities. Researchers found that 64% of participants showed a decline in their ability to perform daily tasks, while 71% of those starting with lower function showed improvement over time. Factors like older age, more severe skin symptoms, and worsening breathing problems were linked to poorer function, which highlights the need for better management of these symptoms. Who this helps: This information can help patients with SSc and their doctors focus on managing symptoms to improve overall physical function.

Plain English
This study examined the changes in hospital care for people with HIV in South Africa between 2004 and 2017. Researchers found that while hospital visits for HIV-related issues decreased significantly during this period, the quality of care improved, leading to better health outcomes for patients. For example, fewer people were hospitalized for HIV complications due to better treatment options, which is crucial for managing the disease effectively. Who this helps: This helps patients living with HIV and healthcare providers in South Africa.

Plain English
This study looked at how worsening shortness of breath (dyspnoea) affects the survival of patients with interstitial lung disease (ILD) related to systemic sclerosis (SSc). Among 2,198 SSc patients followed for about 6 years, 17.7% developed ILD, and of those, 38.3% experienced disease progression. Notably, those who reported worsening shortness of breath in the month before their assessment had a higher death rate, highlighting that patient-reported symptoms are critical for understanding health risks in these patients. Who this helps: This information helps patients and doctors by focusing on the importance of patient-reported symptoms in managing SSc-related lung issues.

Plain English
This study looked at how common pseudo-obstruction is in patients with systemic sclerosis (SSc) and what factors may lead to it. Out of nearly 2,000 patients, only 70 (about 3.6%) experienced pseudo-obstruction, which is more likely in those with longer disease duration, bowel issues, and severe diarrhea. This finding is important because pseudo-obstruction can lead to serious health problems, including malnutrition. Who this helps: Patients with systemic sclerosis and their healthcare teams.

Plain English
This study looked at how well tongue swabs can be used to detect tuberculosis (TB) compared to the usual sputum tests. Researchers found that using a special processing method called vortex bead beating improved detection significantly, and when the swabs were stored in a specific transport medium, it further enhanced results. The findings are important because they suggest that tongue swabs could be a reliable and easier alternative for TB testing, especially in settings where sputum collection is challenging. Who this helps: This helps patients who need TB testing, particularly in areas where traditional methods are difficult to use.

Plain English
This study looked at how well two tests called Cobas MTB and Cobas MTB/RIF-INH can detect tuberculosis (TB) and drug resistance in adults in South Africa. Among 354 people tested, the Cobas MTB test on sputum had a sensitivity of 93.8% and a perfect specificity of 100%, meaning it accurately identified those with and without TB. The findings are important because rapid and accurate TB diagnosis is critical in areas with high rates of the disease, especially for those also living with HIV. Who this helps: This helps patients who need quick and accurate TB diagnosis, especially those with HIV.

Plain English
This study looked at how other health issues (called comorbidities) affect the treatment and survival of patients with a specific type of high blood pressure in the lungs related to systemic sclerosis. Among 238 patients analyzed, those with more health problems (a high comorbidity score of 4 or more) had a greater overall death rate, but treatment choices mainly stayed the same whether patients had high or low comorbidity levels. Importantly, patients receiving combination therapy (more than one type of medication) had better survival rates compared to those on just one treatment. Who this helps: This research is beneficial for patients with systemic sclerosis and their doctors, as it highlights the effectiveness of combination therapies regardless of other health issues.

Plain English
This study investigated how obesity contributes to heart-related issues in the U.S. It found that about 31-32% of people with heart problems also had obesity, and when using advanced analysis, it estimated that obesity was responsible for 21% of heart attacks, 16% of strokes, 38% of heart failure cases, and 19% of overall cardiovascular disease. Understanding this connection emphasizes the importance of addressing obesity to reduce future heart disease complications. Who this helps: Patients dealing with obesity and cardiovascular disease.

Plain English
This study focused on creating clear definitions for how different organs are affected by systemic sclerosis, a serious autoimmune disease. Researchers, including 160 experts and patients, developed nine specific criteria for organ systems like the skin, heart, and lungs, and recommended when these organ issues start. This standardization aims to improve the quality of future research and comparisons in studies about systemic sclerosis, which is crucial for better understanding and treatment. Who this helps: This benefits patients and doctors by improving diagnosis and treatment approaches for systemic sclerosis.

Plain English
This study focused on how doctors assess systemic sclerosis (SSc) in clinical trials using a method called physician global assessment (PhyGA). Researchers interviewed 19 experts, including 18 rheumatologists, and found that while most considered PhyGA helpful for evaluating disease activity, there was a lot of uncertainty about how to use it consistently across trials. This inconsistency poses a challenge, as it could affect the accuracy of measuring treatment responses in clinical studies. Who this helps: This helps doctors and researchers improve the way they assess and treat patients with systemic sclerosis.

Plain English
This study looked at over 38,000 participants from the RECOVERY clinical trial for COVID-19 and compared their characteristics and death rates to more than 346,000 COVID-19 patients hospitalized in England. They found that participants in the RECOVERY trial were generally younger (62.6 years vs. 65.7 years) and less likely to be female (37% vs. 45%) compared to the larger reference group. The death rate after 28 days was similar for both groups, with RECOVERY participants at 23.7% and the reference group at 24.8%, indicating that the results from the RECOVERY trial can be useful for understanding the impact of treatments on a larger population. Who this helps: This helps doctors and healthcare providers understand treatment effectiveness and mortality risk in COVID-19 patients.

Plain English
This study looked at the effectiveness of the ASIG algorithm for screening a lung condition called pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc). Researchers found that the ASIG algorithm performed well, showing a high negative predictive value, which means it accurately identified patients who likely do not have PAH. This is important because it provides a simpler and cheaper way to screen for this serious condition compared to older methods. Who this helps: This helps patients with systemic sclerosis and their doctors by providing an easier screening option for lung health.

Plain English
This study looked at how functional disability progresses in patients with systemic sclerosis, a serious autoimmune disease. Among 426 participants, researchers found two main paths: about 52% had low and stable disability, while 48% experienced high and worsening disability. Those with increasing disability were often older and showed more severe symptoms, which also led to nearly double the risk of death compared to those with stable disability. Who this helps: This information helps doctors better understand patient experiences and risks, enabling them to tailor treatments for systemic sclerosis.

Plain English
This study looked into how fatigue affects people with systemic sclerosis (SSc), a chronic autoimmune disease. Researchers found that fatigue scores were quite similar between those newly diagnosed (37 units) and those who had the disease longer (36 units). Factors like skin involvement, lung issues, and gastrointestinal symptoms were linked to worse fatigue, indicating that managing these problems could help improve patients’ quality of life. Who this helps: This helps patients with systemic sclerosis and their doctors.

Plain English
This study tested a new method using the Xpert MTB/XDR test on leftover samples from tuberculosis patients to check for drug resistance faster and more accurately. Among 763 samples, the Xpert test correctly identified drug resistance in 84% of cases, while traditional tests only achieved 66%. This method reduced the result waiting time from an average of 15 days to just 23 hours, which is crucial for timely treatment decisions. Who this helps: This benefits patients with tuberculosis by providing quicker and more accurate test results.

Plain English
This research looked at how HIV care has changed in South African hospitals from 2004 to 2017. The number of patients getting treatment at hospitals dropped significantly from about 60% in 2004 to only 15% in 2017, as more people started receiving care at clinics instead. Overall, fewer patients were being hospitalized for HIV-related issues over time, especially among the most affected age groups, largely because they were entering treatment in better health. Who this helps: This benefits patients with HIV by improving access to care at clinics and reducing hospitalizations.

Plain English
This study looked at how common gastrointestinal (GI) problems are in people with systemic sclerosis (SSc) and how these issues affect their daily lives and survival. Researchers found that 87% of the 907 patients reported GI symptoms, with 46% to 52% experiencing moderate to severe symptoms like reflux and constipation. These GI issues were linked to lower quality of life, poorer physical health, increased fatigue, and more anxiety and depression, but they didn’t increase the risk of death. Who this helps: This helps patients with scleroderma and their doctors understand the significant impact of gastrointestinal symptoms on health and daily living.

Plain English
This study looked at how well people with Hodgkin lymphoma (HL) are treated in South Africa, especially focusing on those living with HIV and those without. They followed 47 patients for up to 18 months and found that one year after diagnosis, 55% of HIV-positive patients survived compared to 88% of those without HIV. The findings highlight that patients with HIV or cancer spread to the bone marrow had higher early death rates and worse survival overall, indicating the need for better treatment strategies for these high-risk groups. Who this helps: This helps patients with Hodgkin lymphoma, particularly those living with HIV.

Plain English
This study looked at how a specific protein, N-terminal pro-brain natriuretic peptide (NT-proBNP), relates to two heart issues—pulmonary hypertension and diastolic dysfunction—in patients with systemic sclerosis. Among 61 patients, 8% had a high chance of pulmonary hypertension, while 11% had diastolic dysfunction. The study found that patients with these heart issues had significantly higher levels of NT-proBNP compared to those without these conditions, suggesting this protein may help in screening for heart problems in these patients, even though it can't clearly differentiate between the two issues. Who this helps: Patients with systemic sclerosis and their doctors can use this information to better monitor heart-related complications.

Plain English
This study looked at a rare but serious condition called scleroderma renal crisis (SRC) in patients at a large hospital in Australia over a 10-year period. Researchers found that the condition occurred in 3.52% of scleroderma cases, with around 41% of those patients dying within about 2.75 years after the crisis began. They also identified specific risk factors for SRC, including being male and having certain antibodies, which could help doctors identify patients at higher risk. Who this helps: This information is beneficial for doctors treating patients with scleroderma, as it improves understanding and management of SRC.

Plain English
This study looked at how often patients with systemic sclerosis (a chronic autoimmune disease) use opioids and what health issues are related to that use. Out of nearly 2,000 participants, about 12% had used opioids since their diagnosis, with 46% of those continuing to use them over time. The researchers found that opioid use was linked to more severe symptoms, including skin ulcers, joint inflammation, and gastrointestinal issues, as well as worse overall physical and mental wellbeing. Who this helps: This research benefits patients with systemic sclerosis by highlighting the challenges they face and the impact of opioid use on their quality of life.